Oncology M&A: Achieving Better Outcomes?

Posted by Arup Das on Jun 4, 2019 8:00:00 AM

Pranav Srivastava co-wrote this blog post with Arup Das.

Merger and acquisition (M&A) activity for the oncology, pharma and biotech sector is off to a blistering start in 2019. Three huge deals announced in the first two months of the year have set the pace for what could be a record-breaking year: 


>
Read More

Five Key Insights From Oncology First Launches

Posted by Ben Hohn on May 31, 2019 9:27:29 AM

Judith Kulich, Jon Roffman, Cody Powers and Renuka Agarwal co-wrote this blog post with Ben Hohn.

Oncology continues to be the leading therapeutic area for first launches by emerging biopharma companies in the United States. Recent ZS analysis identified 125 U.S. biopharma companies with first launches from 2011 to 2018, and 51 of those were for novel drugs. Of these 51,14 were in oncology—the largest number of any therapeutic area.


>
Read More

Retaining Top Sales Talent Is Hard. What Can Oncology Companies Do About It?

Posted by David Kriesman on Mar 1, 2019 8:00:00 AM

Jamie Kaplan and Bridget Kernan co-wrote this blog post with David Kriesman.

In today’s highly competitive oncology market, retaining top-performing reps has become increasingly difficult no matter what kind of company you are. A growing number of startups are enticing reps away from established companies with an exciting opportunity: the chance to launch new, cutting-edge therapies. The promise (and financial upside) can be quite appealing, yet those same biotech companies must defend against the “serial launcher”: reps cashing in at launch and then moving on to the next new and shiny place. As companies grapple with these retention struggles, they’re quick to point to the reps’ compensation plan as the primary culprit. While that may not be entirely true, there’s often room to improve how your incentive plan helps improve motivation and retention.


>
Read More

Smarter, Faster, Better: Leveraging Artificial Intelligence in Oncology Market Research

Posted by Sonal Singh on Feb 28, 2019 1:27:59 PM

Aritra Das co-authored this blog post with Sonal Singh. 

The oncology market has become increasingly crowded and complex incredibly quickly. As an oncology market researcher, you might be feeling a lot of pressure to up the analytical sophistication in your research and capture nuanced decision-making, all while getting insights to your key stakeholders faster. Have you ever wondered how AI could help solve some of the burning challenges that you’re facing, and help you get robust answers to your questions quickly to help you keep up with the rapidly changing market? Here’s how AI can help.


>
Read More